Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus
- PMID: 17640731
- PMCID: PMC7112560
- DOI: 10.1016/j.cimid.2007.05.009
Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus
Abstract
Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus (SARS-CoV), which has overwhelmed more than 30 countries claiming nearly 8400 cases with over 800 fatalities. Thanks to the unprecedented international collaboration, the whole-genomes of SARS-CoVs were successfully deciphered shortly after the identification of the causative pathogen for outbreak of SARS in southern China, in 2003. Hitherto, the SARS-CoV, as a viral paradigm of emerging infectious entities, has been extensively studied that has ranged from epidemiology, molecular virology/immunology to structural genomics. Also, several lines of breakthroughs have been record-brokenly obtained, that included the finding of ACE2, a functional receptor for the SARS-CoV, solution of the 3CL(pro) structure, a first crystal structure of SARS-related macromolecules, revealing of bats as natural reservoirs for SARS-like viruses and the possible involvement of civet cats in the SARS emergence. This review intends to outline the major progress in the journey of SARS-related exploration, by emphasizing those inaugurated studies with milestone-like significance contributed by Chinese research groups.
Le syndrome respiratoire aigu sévère (SRAS ou SARS), une maladie infectieuse émergeante causée par un nouveau coronavirus (SARS-CoV), toucha plus de 8400 personnes causant 800 morts dans 30 pays différents. Grâce à la mise en place d’une collaboration internationale sans précédent le décryptage du génome complet du SARS-CoV fut réalisé très peu de temps après l’identification de l’agent pathogène suite au déclenchement de l’épidémie dans le sud de la Chine en 2003. Le SARS-CoV en temps que paradigme de maladies infectieuses émergeantes a fait l’objet d’une étude complète en passant de l’épidémiologie, la virologie/immunologie moléculaire à la génomique structurale. Ainsi, c’est en un temps record qu’ont été obtenues des données majeures incluant la découverte de ACE2, un récepteur fonctionnel pour le SARS-CoV, la structure du 3CLpro première structure cristallographique d’une macromolécule du SARS, révélant que la chauve-souris était le réservoir naturel de virus du type SARS, et que la civette était certainement à l’origine de l’émergence du SRAS. Cette revue vise à souligner les progrès majeurs réalisés dans l’exploration du SRAS, en soulignant l’importance des travaux primordiaux et précoces réalisés par les chercheurs chinois.
Figures


Similar articles
-
SARS and MERS: recent insights into emerging coronaviruses.Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Nat Rev Microbiol. 2016. PMID: 27344959 Free PMC article. Review.
-
Bats are natural reservoirs of SARS-like coronaviruses.Science. 2005 Oct 28;310(5748):676-9. doi: 10.1126/science.1118391. Epub 2005 Sep 29. Science. 2005. PMID: 16195424
-
Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.J Virol. 2015 Oct;89(20):10532-47. doi: 10.1128/JVI.01048-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269185 Free PMC article.
-
Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.Hum Vaccin Immunother. 2017 Jan 2;13(1):186-189. doi: 10.1080/21645515.2016.1228500. Epub 2016 Sep 20. Hum Vaccin Immunother. 2017. PMID: 27644155 Free PMC article.
-
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.Infez Med. 2020 Jun 1;28(suppl 1):6-17. Infez Med. 2020. PMID: 32532933 Review.
Cited by
-
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals.Natl Sci Rev. 2022 Jun 23;9(9):nwac122. doi: 10.1093/nsr/nwac122. eCollection 2022 Sep. Natl Sci Rev. 2022. PMID: 36187898 Free PMC article.
-
Advances in developing small molecule SARS 3CLpro inhibitors as potential remedy for corona virus infection.Tetrahedron. 2021 Jan 1;77:131761. doi: 10.1016/j.tet.2020.131761. Epub 2020 Nov 19. Tetrahedron. 2021. PMID: 33230349 Free PMC article. Review.
-
Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018.Emerg Microbes Infect. 2020 Jan 29;9(1):246-255. doi: 10.1080/22221751.2020.1717999. eCollection 2020. Emerg Microbes Infect. 2020. PMID: 31996093 Free PMC article.
-
Emerging viral diseases.Md Med. 2008 Winter;9(1):11, 13-6. Md Med. 2008. PMID: 18491811 Free PMC article. Review. No abstract available.
-
Structure and infrastructure of infectious agent research literature: SARS.Scientometrics. 2011;86(1):195-209. doi: 10.1007/s11192-010-0240-6. Epub 2010 May 30. Scientometrics. 2011. PMID: 32214556 Free PMC article.
References
-
- Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. - PubMed
-
- Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276–278. - PubMed
-
- Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous